cual es mejor tirzepatide vs semaglutide Semaglutide: Comparación Clínica 2026 Comparative safety and side effects

Retatrutide has not received MHRA marketing authorisation and is not approved by NICE, meaning it is currently only accessible in the UK through clinical trials

Head-to-head comparison The cleanest comparison so far is SURPASS-2, which pitted tirzepatide against semaglutide 1 mg in adults with type 2 diabetes (not the obesity dose, but still the most rigorous head-to-head we have)

For weight management, it is approved for adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity, as an adjunct to a reduced-calorie diet and increased physical activity

The researchers who avoid this problem share one habit: they check the concentration label on every new vial and recalculate before the first injection

Cell proliferation detection Cell proliferation was assayed by Ki-67 (Alexa Fluor 488 conjugate) antibody (Cell Signaling cat#11882)